Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00287287
Status:
COMPLETED
Last Update Posted:
2020-06-12
First Post:
2006-02-03
Brief Title:
REVLIMID Lenalidomide for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas
Sponsor:
Organization:
University of Kentucky